Jade Biosciences Inc (JBIO)

May 05, 2026

2 small-cap stocks with big potential to buy under $30 - MSN

May 05, 2026

May 02, 2026

Jade Biosciences Reshapes Clinical Leadership As Valuation Debate Persists - Sahm

May 02, 2026

May 01, 2026

2 Small-Cap Stocks With Big Potential to Buy Under $30 - Barchart.com

May 01, 2026

Apr 29, 2026

Jade Biosciences (NASDAQ:JBIO) Stock Price Down 9.6%Here's What Happened - MarketBeat

Apr 29, 2026

Apr 29, 2026

What is HC Wainwright's Forecast for JBIO FY2030 Earnings? - MarketBeat

Apr 29, 2026

Apr 28, 2026

Jade Biosciences (NASDAQ: JBIO) outlines 2026 director votes, auditor and jury waiver - Stock Titan

Apr 28, 2026

Apr 28, 2026

Jade Biosciences (NASDAQ:JBIO) Sets New 1-Year HighHere's What Happened - MarketBeat

Apr 28, 2026

Apr 28, 2026

FY2028 Earnings Forecast for JBIO Issued By HC Wainwright - MarketBeat

Apr 28, 2026

Apr 28, 2026

Jade Biosciences stock hits 52-week high at 27.44 USD By Investing.com - Investing.com South Africa

Apr 28, 2026

Apr 27, 2026

Jade Biosciences (JBIO) price target increased by 10.24% to 28.82 - MSN

Apr 27, 2026

Apr 27, 2026

BlackRock (NYSE: JBIO) reports 2.3M JADE stake, 4.7% disclosed - Stock Titan

Apr 27, 2026

Apr 27, 2026

Jade Biosciences stock hits 52-week high at 27.44 USD - Investing.com

Apr 27, 2026

Apr 27, 2026

Jade Biosciences stock price target raised to $45 by H.C. Wainwright - Investing.com Canada

Apr 27, 2026

Apr 27, 2026

H.C. Wainwright Maintains Jade Biosciences(JBIO.US) With Buy Rating, Raises Target Price to $45 - Moomoo

Apr 27, 2026

Apr 27, 2026

Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Apr 27, 2026

Apr 27, 2026

A Look At Jade Biosciences (JBIO) Valuation After Its Recent Share Price Surge - Sahm

Apr 27, 2026

Apr 26, 2026

Jade Biosciences, Inc. (NASDAQ:JBIO) Short Interest Update - MarketBeat

Apr 26, 2026

Apr 23, 2026

Jade Biosciences, Inc. Grants Equity Award to New Chief Medical Officer Edward R. Conner, M.D. - Quiver Quantitative

Apr 23, 2026

Apr 23, 2026

New Jade medical chief gets 500,000 stock options at $25.38 - Stock Titan

Apr 23, 2026

Apr 23, 2026

Jade Biosciences Elevates Andrew King to R&D President - The Globe and Mail

Apr 23, 2026

Apr 22, 2026

Jade Biosciences names Edward Conner as chief medical officer By Investing.com - Investing.com Australia

Apr 22, 2026

Apr 22, 2026

Jade Biosciences (NASDAQ:JBIO) Shares Up 9.7%What's Next? - MarketBeat

Apr 22, 2026

Apr 22, 2026

Jade Biosciences names Edward Conner as chief medical officer - Investing.com

Apr 22, 2026

Apr 22, 2026

Jade Biosciences Appoints Andrew King as President of Research & Development – 8-K SEC Filing Update - Minichart

Apr 22, 2026

Apr 22, 2026

Jade Biosciences appoints Andrew King as president of research and development - Investing.com UK

Apr 22, 2026

Apr 22, 2026

Jade Biosciences appoints Andrew King as president of research and development By Investing.com - Investing.com South Africa

Apr 22, 2026

Apr 22, 2026

Jade Biosciences, Inc. Announces Executive Changes - marketscreener.com

Apr 22, 2026

Apr 22, 2026

Andrew King becomes President of R&D at Jade Biosciences (NASDAQ: JBIO) - Stock Titan

Apr 22, 2026

Apr 22, 2026

Jade Biosciences Appoints Edward R. Conner, M.D., as Chief Medical Officer - The Manila Times

Apr 22, 2026

Apr 22, 2026

Jade brings in new CMO ahead of kidney disease trial and Phase 1 data - Stock Titan

Apr 22, 2026

Apr 21, 2026

We're Hopeful That Jade Biosciences (NASDAQ:JBIO) Will Use Its Cash Wisely - simplywall.st

Apr 21, 2026

Apr 21, 2026

We're Not Very Worried About Jade Biosciences' (NASDAQ:JBIO) Cash Burn Rate - Moomoo

Apr 21, 2026

Apr 19, 2026

Jade Biosciences: Caution Advised Before Clinical Trial Results (NASDAQ:JBIO) - Seeking Alpha

Apr 19, 2026

Apr 18, 2026

Jade Biosciences (JBIO) Stock Hits 52-Week High (+4.43%) 2026-04-18Bullish Pattern - Xã Thanh Hà

Apr 18, 2026

Apr 18, 2026

Jade Biosciences stock hits 52-week high at 23.23 USD By Investing.com - Investing.com India

Apr 18, 2026

Apr 17, 2026

Jade Biosciences (NASDAQ: JBIO) — director votes, auditor and jury‑waiver amendment - Stock Titan

Apr 17, 2026

Apr 17, 2026

Jade Biosciences stock hits 52-week high at 23.23 USD - Investing.com

Apr 17, 2026

Apr 17, 2026

Jade Biosciences Inc expected to post a loss of 48 cents a shareEarnings Preview - TradingView

Apr 17, 2026

Apr 16, 2026

Jade Biosciences (NASDAQ:JBIO) Stock Price Up 9.7%Should You Buy? - MarketBeat

Apr 16, 2026

Apr 16, 2026

Top Inhibikase Therapeutics (IKT) Competitors 2026 - MarketBeat

Apr 16, 2026

Apr 14, 2026

Jade Biosciences (JBIO) price target increased by 16.48% to 26.14 - MSN

Apr 14, 2026

Apr 13, 2026

Can Jade Biosciences (JBIO) Stock Maintain Growth | Price at $18.30, Up 2.29%Diversification - Newser

Apr 13, 2026

Apr 11, 2026

Volume Report: Is Jade Biosciences Inc a stock for growth or value investorsInsider Buying & AI Forecast for Swing Trade Picks - baoquankhu1.vn

Apr 11, 2026

Apr 11, 2026

Jade Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Update - ADVFN

Apr 11, 2026

Apr 11, 2026

Aug Drivers: Is Jade Biosciences Inc a stock for growth or value investors2026 PreEarnings & Weekly Watchlist of Top Performers - baoquankhu1.vn

Apr 11, 2026

Apr 10, 2026

Jade Biosciences (NASDAQ:JBIO) Rating Increased to Hold at Zacks Research - MarketBeat

Apr 10, 2026

Apr 09, 2026

Jade Biosciences (NASDAQ:JBIO) Trading Up 7.9%What's Next? - MarketBeat

Apr 09, 2026

Apr 08, 2026

867,284 Shares in Jade Biosciences, Inc. $JBIO Bought by Aberdeen Group plc - Defense World

Apr 08, 2026